Update to the MCP SDK for C# brings an improved authentication protocol, elicitation support, structured tool output, and ...

Connect Biopharma’s Phase 2b trial indicated a reduction in annualized asthma exacerbation rates by up to 74% in patients with specific inflammatory markers.